Skip to content

Heratsi

Active
Private limited companyfounded 2014active for 12 yearsRue Joseph Sneessens 15, 1300 Wavre, BelgiumKBO/BCE: BE 0551.895.653
Summary

Heratsi has been active since 2014 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €20,460 and a net result of €85,880. The figures fluctuate too strongly year-on-year for a reliable trend projection. Its solvency ranks better than 19% of 20,358 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Activity
General medical practice
NACE 86210
1 site
Size
€109,241total assets 2025
Equity
€20,460
Profit
€85,880
Turnover not published (micro format)
Financial health
93 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Structure
Accounts 112 days early0 of 2 deeds read
Why 93lowers riskSector: Human health activities (NACE 86)Liquidity: current ratio 1.18, cash €98,112Size: total assets €109,241Figures for financial year 2025 (filed 10-04-2026)Show the evidence

Checked score

Score 2025
93 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 42% of its sector peers (NACE 86, micro)
Financial strength · tick = 2024
Strong
Solvency 44+3
equity 18.7% of total assets
Liquidity 55+1
short-term debt 81.3% · cash 89.8%
Profitability 100=
return on assets 78.6%
Bankruptcy probability, 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,058 companies, NACE 86, micro)
Last 24 months 11-2024: 0.1% 12-2024: 0.1%● unchanged vs 11-2024 01-2025: 0.1%● unchanged vs 12-2024 02-2025: 0.1%● unchanged vs 01-2025 03-2025: 0.1%● unchanged vs 02-2025highest value 04-2025: < 0.1%▼ -0.1 percentage points vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026lowest value 06-2026: < 0.1%● unchanged vs 05-2026lowest value 07-2026: < 0.1%● unchanged vs 06-2026lowest value 08-2026: < 0.1%● unchanged vs 07-2026lowest value 09-2026: < 0.1%● unchanged vs 08-2026lowest value 10-2026: < 0.1%● unchanged vs 09-2026lowest value
Credit of up to €1,500 on 30-day terms is acceptable
Liquidity tight (current ratio 1.18, compared with 1.12 in 2024, below the usual 1.5; short-term debt: 81.3% and cash: 89.8% of total assets), and 81.3% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro): better than 19% on solvency, 31% on liquidity, 80% on profitability and 37% on growth.

The bankruptcy probability was computed on 15-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Liquidity: current ratio 1.18, cash €98,112
NBB · annual accounts
lowers risk · Size: total assets €109,241
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Figures for financial year 2025 (filed 10-04-2026)
NBB · annual accounts
raises risk · Weak solvency vs sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 19% of 20358 sector peers (2025).
NBB · sector comparison
Position among 20358 sector peers
Solvency
better than 19%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 10-04-2026, 112 days ahead of the deadline.
NBB · 10 filings
Deviation from the deadline
2025
112 days early
2024
57 days early
2023
47 days early
2022
55 days early
2021
51 days early
2020
51 days early
2019
42 days early
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

This company filed its last 7 accounts on average 59 days before the deadline; the sector median (NACE 86) for financial year 2024 is 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 6 June (4 of the last 5 filed years within 30 days of that day).
Companies Code · seven months
Where today falls in the filing period
15-10-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
Searched since 2021.
KBO publications · our coverage
  1. Annual accounts filedfinancial year 2025 · micro…
  2. Annual accounts filedfinancial year 2024 · micro…
  3. Annual accounts filedfinancial year 2023 · micro…

Financials · financial year 2025, micro format

Equity
€20,460=
2024 · €20,460
Total assets
€109,241▼ 15.3%
2024 · €128,964
Net result
€85,880▲ 4.1%
2024 · €82,468
Working capital
€15,725▲ 26.0%
2024 · €12,479
Trend over the years

2021 to 2025, 5 financial years 2018 to 2025, 8 financial years

After the dip in 2022 the operating result has climbed three years in a row; 2025 is 4% above 2024.

What the company sold each financial year and what was left of it. A loss stands below the zero line.

Operating result€109,569 2025 Net result€85,880 2025

Use the arrow keys on the chart for the figures per year.

Sector: the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30. Dashed line: the median. Available for Net result, Equity, Total assets, Working capital, Solvency, Current ratio, Return on assets (ROA).

Every figure with its change against the financial year before
favourable unfavourable
Line20182019202020212022202320242025
Operating result€39,984-€68,608▲ 71.6%€59,264▼ 13.6%€115,539▲ 95.0%€62,217▼ 46.2%€97,342▲ 56.5%€105,464▲ 8.3%€109,569▲ 3.9%
Net result€26,758-€52,993▲ 98.0%€45,107within the sector's middle half▼ 14.9%€89,002within the sector's middle half▲ 97.3%€47,841within the sector's middle half▼ 46.2%€76,689within the sector's middle half▲ 60.3%€82,468within the sector's middle half▲ 7.5%€85,880within the sector's middle half▲ 4.1%
Equity€222,863-€20,460▼ 90.8%€65,567within the sector's middle half▲ 220%€118,226within the sector's middle half▲ 80.3%€70,437within the sector's middle half▼ 40.4%€43,679below the sector's middle half▼ 38.0%€20,460below the sector's middle half▼ 53.2%€20,460below the sector's middle half=
Total assets€223,764-€76,407▼ 65.9%€72,403below the sector's middle half▼ 5.2%€261,257within the sector's middle half▲ 261%€167,680within the sector's middle half▼ 35.8%€153,356within the sector's middle half▼ 8.5%€128,964within the sector's middle half▼ 15.9%€109,241below the sector's middle half▼ 15.3%
Debt€901-€55,947▲ 6,107%€6,836▼ 87.8%€143,031▲ 1,992%€97,243▼ 32.0%€109,677▲ 12.8%€108,504▼ 1.1%€88,781▼ 18.2%
Working capital€222,863-€20,170▼ 90.9%€64,280within the sector's middle half▲ 219%€116,661within the sector's middle half▲ 81.5%€60,916within the sector's middle half▼ 47.8%€37,528within the sector's middle half▼ 38.4%€12,479below the sector's middle half▼ 66.7%€15,725within the sector's middle half▲ 26.0%
Solvency99.6%-26.8%▼ 72.8pp90.6%above the sector's middle half▲ 63.8pp45.3%within the sector's middle half▼ 45.3pp42.0%within the sector's middle half▼ 3.2pp28.5%below the sector's middle half▼ 13.5pp15.9%below the sector's middle half▼ 12.6pp18.7%below the sector's middle half▲ 2.9pp
Current ratio1.3610.40above the sector's middle half▲ 9.041.82within the sector's middle half▼ 8.591.63within the sector's middle half▼ 0.191.34below the sector's middle half▼ 0.281.12below the sector's middle half▼ 0.231.18within the sector's middle half▲ 0.06
Return on assets (ROA)12.0%-69.4%▲ 57.4pp62.3%above the sector's middle half▼ 7.1pp34.1%above the sector's middle half▼ 28.2pp28.5%within the sector's middle half▼ 5.5pp50.0%above the sector's middle half▲ 21.5pp63.9%above the sector's middle half▲ 13.9pp78.6%above the sector's middle half▲ 14.7pp
above within below the middle half of NACE 86, Human health activities: a quarter of companies sit below it, a quarter above. Each year compared with accounts in the same format, and only where there are at least 30.
Turnover and EBIT margin not published: the micro format does not require them.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Assets €109,241
Fixed assets €4,735 ▼ 40.7%
Current assets €104,505 ▼ 13.6%
Equity and liabilities €109,241
Equity €20,460 =
Debt €88,781 ▼ 18.2%
Debt's share of the balance-sheet total falls from 84.1% to 81.3%. Debt is lower.
Key figures and ratios
2025 value · change against 2024
EBITDA
€112,814▲
2024 · €108,935
Cash flow
€89,126▲
2024 · €85,938
Debt to equity
4.34▼
2024 · 5.30
ROE
419.7%▲
2024 · 403.1%
Interest coverage
over 100
2024 · over 100
Debt ≤ 1 year
€88,781▼
2024 · €108,504
Income taxes
€23,616▲
2024 · €22,888
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 5,053 companies that looked in July 2024 the way this one looks now, 1.6% went bankrupt within 24 months and 95.9% are still going.

  • Micro
  • 10 to 20 years old
  • solvency 10 to 30%
  • a profit of 5% of the balance sheet or more
1.6% went bankrupt
2.4% stopped otherwise
95.9% still going

A further 0.1% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a lower bankruptcy probability: < 0.1% over twelve months. The score reads more about this company than the group's four characteristics; both figures are right about what they measure.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,474 companies of July 2024 its group's bankruptcy share. Expected: 1.6%; actually bankrupt within 24 months: 1.7%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 1.0%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 3.0% 3.1%
10 5.6% 6.2%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 74.5% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 5,053 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 39 lines
Balance sheet Code20242025
Assets
Total assets20/58€128,964€109,241▼
Fixed assets21/28€7,981€4,735▼
Tangible fixed assets22/27€7,981€4,735▼
Furniture and vehicles24€7,181€3,935▼
Other tangible fixed assets26€800€800=
Current assets29/58€120,984€104,505▼
Amounts receivable after more than one year29€27,000-
Other amounts receivable291€27,000-
Amounts receivable within one year40/41€673€916▲
Other amounts receivable41€673€916▲
Cash at bank and in hand54/58€88,364€98,112▲
Deferred charges and accrued income490/1€4,947€5,477▲
Equity and liabilities
Total equity and liabilities10/49€128,964€109,241▼
Equity10/15€20,460€20,460=
Contributions10/11€18,600€18,600=
Reserves13€1,860€1,860=
Non-distributable reserves130/1€1,860€1,860=
Reserves not available under the articles1311€1,860€1,860=
Amounts payable17/49€108,504€88,781▼
Amounts payable within one year42/48€108,504€88,781▼
Trade debts44€2,818€284▼
Suppliers440/4€2,818€284▼
Taxes, remuneration and social security45-€2,616
Taxes450/3-€2,616
Other amounts payable47/48€105,687€85,880▼
Income statement Code20242025
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€3,470€3,245▼
Other operating charges640/8€926€973▲
Gross operating margin9900€109,860€113,787▲
Operating profit (loss)9901€105,464€109,569▲
Financial charges65/66B€108€72▼
Recurring financial charges65€108€72▼
Profit (loss) for the period before taxes9903€105,356€109,497▲
Income taxes67/77€22,888€23,616▲
Profit (loss) for the period9904€82,468€85,880▲
Profit (loss) for the period to be appropriated9905€82,468€85,880▲
Appropriation of the result
Profit (loss) to be appropriated9906€82,468€85,880▲
Transfer from equity791/2€23,219-
Profit to be distributed694/7€105,687€85,880▼
Return on contributions (dividend)694€105,687€85,880▼

The notes to these accounts (6 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20182019202020212022202320242025Change
Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630€4,833€73€351€522€1,540€3,371€3,470€3,245▼ 6.5%
Other operating charges640/8---€810€810€931€926€973▲ 5.1%
Gross operating margin9900€46,684€71,068€60,400€116,871€64,567€101,643€109,860€113,787▲ 3.6%
Operating profit (loss)9901€39,984€68,608€59,264€115,539€62,217€97,342€105,464€109,569▲ 3.9%
Financial income75/76B-----€0---
Recurring financial income75-€0---€0---
Financial charges65/66B---€902€457€72€108€72▼ 33.3%
Recurring financial charges65€650€1,593€1,264€902€457€72€108€72▼ 33.3%
Profit (loss) for the period before taxes9903€39,333€67,015€58,000€114,638€61,760€97,270€105,356€109,497▲ 3.9%
Income taxes67/77€12,576€14,022€12,893€25,635€13,919€20,581€22,888€23,616▲ 3.2%
Profit (loss) for the period9904€26,758€52,993€45,107€89,002€47,841€76,689€82,468€85,880▲ 4.1%
Profit (loss) for the period to be appropriated9905€26,758€52,993€45,107€89,002€47,841€76,689€82,468€85,880▲ 4.1%
Line20182019202020212022202320242025Change
Assets
Total assets20/58€223,764€76,407€72,403€261,257€167,680€153,356€128,964€109,241▼ 15.3%
Fixed assets21/28-€290€1,287€1,565€9,521€6,151€7,981€4,735▼ 40.7%
Intangible fixed assets21-€290€218€145€73----
Tangible fixed assets22/27--€1,069€1,420€9,449€6,151€7,981€4,735▼ 40.7%
Furniture and vehicles24---€620€8,649€5,351€7,181€3,935▼ 45.2%
Other tangible fixed assets26---€800€800€800€800€800=
Current assets29/58€223,764€76,117€71,116€259,692€158,158€147,205€120,984€104,505▼ 13.6%
Amounts receivable after more than one year29----€81,000€54,000€27,000--
Other amounts receivable291----€81,000€54,000€27,000--
Amounts receivable within one year40/41€13,749€10,767-€35,821€15,903€248€673€916▲ 36.2%
Other amounts receivable41---€35,821€15,903€248€673€916▲ 36.2%
Cash at bank and in hand54/58€201,139€63,490€69,482€222,249€58,991€89,301€88,364€98,112▲ 11.0%
Deferred charges and accrued income490/1---€1,622€2,264€3,657€4,947€5,477▲ 10.7%
Equity and liabilities
Total equity and liabilities10/49€223,764€76,407€72,403€261,257€167,680€153,356€128,964€109,241▼ 15.3%
Equity10/15€222,863€20,460€65,567€118,226€70,437€43,679€20,460€20,460=
Contributions10/11€18,600€18,600-€18,600€18,600€18,600€18,600€18,600=
Reserves13€203,752€1,860€46,967€99,626€51,837€25,079€1,860€1,860=
Non-distributable reserves130/1---€1,860€1,860€1,860€1,860€1,860=
Reserves not available under the articles1311---€1,860€1,860€1,860€1,860€1,860=
Distributable reserves133---€97,766€49,977€23,219---
Profit (loss) carried forward14€511€511€511------
Amounts payable17/49€901€55,947€6,836€143,031€97,243€109,677€108,504€88,781▼ 18.2%
Amounts payable within one year42/48€901€55,947€6,836€143,031€97,243€109,677€108,504€88,781▼ 18.2%
Trade debts44€46€1,432€1,683€1,571€1,613€1,650€2,818€284▼ 89.9%
Suppliers440/4---€1,571€1,613€1,650€2,818€284▼ 89.9%
Taxes, remuneration and social security45-----€4,581-€2,616-
Taxes450/3-----€4,581-€2,616-
Other amounts payable47/48---€141,461€95,630€103,446€105,687€85,880▼ 18.7%
Line20182019202020212022202320242025Change
Profit (loss) for the period9904€26,758€52,993€45,107€89,002€47,841€76,689€82,468€85,880▲ 4.1%
+ Depreciation and write-downs630€4,833€73€351€522€1,540€3,371€3,470€3,245▼ 6.5%
Operating cash flow (approximation)€31,591€53,066€45,457€89,524€49,381€80,059€85,938€89,126▲ 3.7%
Investment in fixed assets (approximation)---€1,347-€800-€9,496€0-€5,300€0-
Change in cash--€137,649€5,993€152,766-€163,258€30,309-€937€9,748-

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Latest 10 of 12 filings with the National Bank
Financial year Type Filed Reference
31-12-2025 micro format 10-04-2026 2026-00076461
31-12-2024 micro format 04-06-2025 2025-00117794
31-12-2023 micro format 14-06-2024 2024-00129184
31-12-2022 micro format 06-06-2023 2023-00110451
31-12-2021 micro format 10-06-2022 2022-20055411
31-12-2020 micro format 10-06-2021 2021-18800174
31-12-2019 micro format 19-06-2020 2020-18400522
31-12-2018 micro format 31-05-2019 2019-15400175
31-12-2017 micro format 11-06-2018 2018-17400576
31-12-2016 micro format 31-05-2017 2017-14300357

Show all 12 filings

Similar companies · same sector, comparable size

Of the 9,126 active companies whose main activity is general medical practice (NACE 86210), figures are known for 6,433. 3,404 are within a factor 10 of this equity. These 5 are the closest to it. See the whole sector

Public contracts: No European public contracts awarded found since October 2016. Contracts below the EU thresholds are not in TED.

Directors

Directors
No directors read yet: 0 of 2 Gazette acts processed. See the directors and other office holders in the KBO →

Owners and capital

Owners

No owners or capital events in the accounts and acts we read.

History

Heratsi was incorporated on 5 May 2014.1 Total assets fell from €223,764 in 2018 to €109,241 in 2025.2

  1. 1KBO register
  2. 2National Bank, annual accounts 2018 and 2025

Acts, filings and financial milestones

Next filing, financial year 2026, expected by 31-07-2027
2026
10-04
NBB filing Annual accounts filed
financial year 2025 · micro format
2025
04-06
NBB filing Annual accounts filed
financial year 2024 · micro format
2024
14-06
NBB filing Annual accounts filed
financial year 2023 · micro format
2023
06-06
NBB filing Annual accounts filed
financial year 2022 · micro format
2022
10-06
NBB filing Annual accounts filed
financial year 2021 · micro format
2021
31-12
Financial Highest result from 2018 to 2025net €89,002 ▲97.3%
Operating result €115,539, net result €89,002, both a record.
31-12
Financial Equity above €100,000equity €118,226 ▲80.3%
A profit in every financial year since 2018 builds equity to €118,226.
10-06
NBB filing Annual accounts filed
financial year 2020 · micro format
2020
31-12
Financial Liquidity more than 7 timescurrent ratio 10.40
Current ratio from 1.36 to 10.40; short-term debt falls from €55,947 to €6,836.
19-06
NBB filing Annual accounts filed
financial year 2019 · micro format
2019
31-05
NBB filing Annual accounts filed
financial year 2018 · micro format
2018
11-06
NBB filing Annual accounts filed
financial year 2017 · micro format
2017
31-05
NBB filing Annual accounts filed
financial year 2016 · micro format
Financial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 12 annual accounts filed, the latest 10 are here; all 12 are under Financials.
0 of 2 deeds read
About the unread acts

We know of 2 Belgian Official Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Register details

Identification
Legal formPrivate limited company
Founded05-05-2014
Financial year end31-12
Activities, NACEBEL 2025
86210General medical practice
E-invoicing
Reachable via Peppol
Peppol ID 0208:0551895653
Also 9925:BE0551895653
Registered 24-12-2025

If you follow this company, Checked tells you the day it leaves the Peppol register.

Register as of 15 October 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.

Environmental permits: No permit applications found in Flanders. Brussels and Wallonia do not publish the applicant.

Sites & property

Location & real-estate footprint
Registered office, Wavre · 1 establishment unit since 2014
registered office establishment The establishment unit on the map
Ground area
3,721 m²
Building footprint
223 m²
Building volume
1,160 m³
Parcel 25055B0338/00V005, Wallonia · tallest building 7.6 m. Linked by address, not a title deed.
3 companies at this address See who is registered here
1 establishment unit
Rue Joseph Sneessens 15, 1300 Wavre
General medical practice
since 2014unit no. 2.231.902.989
1 parcel
Wallonia 1 (100%)
Cadastral parcel Region Area Buildings Height / floors
25055B0338/00V005 Wallonia 3,721 m² 1 · 223 m² 7.6 m · 2
How the parcels are linked
Good to know
The parcel matches the address exactly.